Journal Title
Title of Journal:
|
|
Publisher
Springer, New York, NY
|
|
|
|
Authors: J Rick Turner
Publish Date: 2011
Volume: , Issue: , Pages: 23-32
Abstract
A drug must demonstrate efficacy to be given marketing approval That is it must provide therapeutic benefit to patients with the disease or condition of clinical concern Efficacy is assessed in two ways there must be compelling evidence of both statistically significant efficacy and clinically significant efficacy The former is addressed via formalized hypothesis testing involving the creation of a research question a research hypothesis and the null hypothesis The latter is addressed via the placement of confidence intervals around the drug’s treatment effect While important the demonstration of statistically significant efficacy alone does not equate to the demonstration of a biologically and medically important degree of efficacy Statistical significance addresses the reliability of the treatment effect while clinical significance addresses the magnitude of the treatment effect ie its degree of therapeutic benefit
Keywords:
.
|
Other Papers In This Journal:
|